Cerity Partners LLC Sells 538,657 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Cerity Partners LLC lessened its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 80.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 133,447 shares of the pharmacy operator's stock after selling 538,657 shares during the period. Cerity Partners LLC's holdings in Walgreens Boots Alliance were worth $1,224,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the business. Brooklyn Investment Group lifted its stake in shares of Walgreens Boots Alliance by 21.1% in the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator's stock worth $44,000 after buying an additional 830 shares during the last quarter. First Financial Corp IN lifted its position in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock worth $25,000 after acquiring an additional 885 shares during the last quarter. CWA Asset Management Group LLC boosted its holdings in Walgreens Boots Alliance by 9.2% during the fourth quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator's stock valued at $120,000 after acquiring an additional 1,084 shares during the period. Metis Global Partners LLC grew its position in shares of Walgreens Boots Alliance by 4.9% in the fourth quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator's stock valued at $222,000 after purchasing an additional 1,118 shares during the last quarter. Finally, Harbour Investments Inc. increased its stake in shares of Walgreens Boots Alliance by 4.3% in the fourth quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator's stock worth $265,000 after purchasing an additional 1,165 shares during the period. 58.59% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages recently weighed in on WBA. Royal Bank of Canada increased their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research note on Wednesday, January 15th. Truist Financial lowered their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research note on Friday, January 31st. Wolfe Research upgraded shares of Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. StockNews.com started coverage on shares of Walgreens Boots Alliance in a research report on Saturday, April 19th. They issued a "hold" rating on the stock. Finally, Bank of America upped their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research report on Monday, January 13th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, Walgreens Boots Alliance currently has a consensus rating of "Hold" and an average price target of $10.59.

Walgreens Boots Alliance Price Performance

Shares of WBA stock traded down $0.02 during trading hours on Thursday, hitting $10.97. The company had a trading volume of 1,528,566 shares, compared to its average volume of 20,964,670. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $18.83. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The firm's fifty day moving average is $10.93 and its 200 day moving average is $10.18. The firm has a market capitalization of $9.49 billion, a price-to-earnings ratio of -1.07, a PEG ratio of 1.31 and a beta of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating analysts' consensus estimates of $0.53 by $0.10. The firm had revenue of $38.59 billion for the quarter, compared to analysts' expectations of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business's revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.20 earnings per share. On average, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.